← All trials
NCT04277897
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2020
- Primary completion
- Jun 30, 2020
- Completion date
- Sep 30, 2020
- First posted
- Feb 20, 2020
- Last posted
- Feb 20, 2020
- Enrollment
- 69
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Xintong Pharmacy CompanyLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.